Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty

Abstract

Aspirin is more effective than warfarin for the prevention of VTE following SBTKA, and serves as the more appropriate agent for VTE prophylaxis for patients in all risk categories. Furthermore, patients undergoing SBTKA are at a substantially increased risk of VTE, even more so for those with significant underlying risk factors. Patients should be informed about the risks associated with undergoing SBTKA. Cite this article: <i>Bone Joint J</i> 2018;100-B(1 Supple A):68-75.